Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CHIVAS-IgG: A Blinded, Randomised, Placebo-Controlled Human Infection Trial in Healthy Adults of Passive Immunisation With Intravenous Immunoglobulin to Explore Protective Immunity Against Strep A Pharyngitis (A PISA Consortium Study).

NCT07864350 is registered in ClinicalTrials.gov with Murdoch Childrens Research Institute as lead sponsor.

NCT NCT07864350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07864350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CHIVAS-IgG: A Blinded, Randomised, Placebo-Controlled Human Infection Trial in Healthy Adults of Passive Immunisation With Intravenous Immunoglobulin to Explore Protective Immunity Against Strep A Pharyngitis (A PISA Consortium Study).
Lead sponsor
Murdoch Childrens Research Institute
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
July 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

streptococcal pharyngitis